Literature DB >> 20566079

Direct superficial temporal vein approach for dural carotid cavernous fistula.

S Matsubara1, K Kazekawa, H Aikawa, M Onizuka, M Tsutsumi, M Ikou, T Kodama, K Nii, S Nagata, A Tanaka.   

Abstract

SUMMARY: We present an alternative endovascular approach to treat dural carotid cavernous fistulae (dural CCF) that drain only into the superior ophthalmic vein. Four cases of cavernous dural AVFs that could not be treated via the inferior petrosal vein were accessed via the direct superficial temporal vein approach through the superior ophthalmic vein. Successful embolization was documented radiographically and clinically in all patients. The trans-superficial temporal vein approach is safe and useful for inaccessible dural CCFs through the inferior petrosal sinus.

Entities:  

Year:  2007        PMID: 20566079      PMCID: PMC3345469          DOI: 10.1177/15910199070130S108

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  11 in total

1.  Treatment of dural carotid-cavernous fistulas via the superior ophthalmic vein.

Authors:  L H Monsein; G M Debrun; N R Miller; H J Nauta; J R Chazaly
Journal:  AJNR Am J Neuroradiol       Date:  1991 May-Jun       Impact factor: 3.825

2.  Acute exophthalmos during treatment of a cavernous sinus-dural fistula through the superior ophthalmic vein.

Authors:  M H Devoto; J E Egbert; T A Tomsick; D R Kulwin
Journal:  Arch Ophthalmol       Date:  1997-06

3.  Treatment of bilateral spontaneous dural carotid-cavernous fistulas by coils and sclerotherapy. Case report.

Authors:  P Courtheoux; D Labbe; C Hamel; P J Lecoq; M Jahara; J Théron
Journal:  J Neurosurg       Date:  1987-03       Impact factor: 5.115

4.  Cavernous sinus venography.

Authors:  P C Shiu; W N Hanafee; G H Wilson; R W Rand
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1968-09

5.  True anatomical compartmentalization of the cavernous sinus in a patient with bilateral cavernous dural arteriovenous fistulae. Case report.

Authors:  J C Chaloupka; D Goller; R A Goldberg; G R Duckwiler; N A Martin; F Viñuela
Journal:  J Neurosurg       Date:  1993-10       Impact factor: 5.115

6.  Severe vision loss and neovascular glaucoma complicating superior ophthalmic vein approach to carotid-cavernous sinus fistula.

Authors:  N Gupta; D O Kikkawa; L Levi; R N Weinreb
Journal:  Am J Ophthalmol       Date:  1997-12       Impact factor: 5.258

7.  Intracranial dural arteriovenous malformations: factors predisposing to an aggressive neurological course.

Authors:  I A Awad; J R Little; W P Akarawi; J Ahl
Journal:  J Neurosurg       Date:  1990-06       Impact factor: 5.115

8.  Spontaneous carotid-cavernous fistulas: clinical, radiological, and therapeutic considerations. Experience with 20 cases.

Authors:  F Viñuela; A J Fox; G M Debrun; S J Peerless; C G Drake
Journal:  J Neurosurg       Date:  1984-05       Impact factor: 5.115

9.  Dural fistulas involving the cavernous sinus: results of treatment in 30 patients.

Authors:  V V Halbach; R T Higashida; G B Hieshima; M Reicher; D Norman; T H Newton
Journal:  Radiology       Date:  1987-05       Impact factor: 11.105

Review 10.  Angiographic workup of a carotid cavernous sinus fistula (CCF) or what information does the interventionalist need for treatment? .

Authors:  G M Debrun
Journal:  Surg Neurol       Date:  1995-07
View more
  2 in total

Review 1.  The working road map in a neurosurgical Hybrid Angio-Surgical suite------ development and practice of a neurosurgical Hybrid Angio-Surgical suite.

Authors:  Zeguang Ren; Shuo Wang; Kaya Xu; Maxim Mokin; Yuanli Zhao; Yong Cao; Jia Wang; Hancheng Qiu; Siviero Agazzi; Harry van Loveren; Jizong Zhao
Journal:  Chin Neurosurg J       Date:  2018-03-22

2.  Middle temporal vein access for transvenous embolization of Cavernous sinus dural arteriovenous fistula: A case report and review of literature.

Authors:  Su-Chel Kim; Jae-Hyun Kim; Chang-Hyun Kim; Chang-Young Lee
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2021-10-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.